Navigation Links
Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting

-- New Subset Analyses To Be Presented --

SAN FRANCISCO, April 24, 2007 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that data from the Company's Phase 2 efficacy study of Dimebon(TM) in Alzheimer's disease will be presented for the first time in the United States at the American Academy of Neurology's 59th Annual Meeting in Boston on Thursday, May 3, at 4:15 p.m. Eastern time. The presentation will include new data from both the mild and moderate subgroups of patients with Alzheimer's disease. Medivation will hold a teleconference on Friday, May 4, at 9:00 a.m. Eastern time with David Hung, M.D., president and chief executive officer of Medivation, Lynn Seely, M.D., chief medical officer, and Rachelle S. Doody, M.D., Ph.D., lead investigator, to discuss the data.

Dr. Doody will present the data (abstract #S51.003), Dimebon Improves Cognition, Function and Behavior in Patients with Mild-Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Study, during the "Aging and Dementia" session of the conference. Dr. Doody holds the Effie Marie Cain Chair in Alzheimer's Disease Research at the Alzheimer's Disease and Memory Disorders Center, in Houston.

In addition, these data have been selected by the American Academy of Neurology for inclusion in the Scientific Topic Highlights session on Thursday, May 3, at 6:00 p.m. Eastern time. During this session, expert moderators will summarize the most interesting and relevant research at the meeting in a particular topic.

Teleconference/Webcast Details

To participate in the live call by telephone, please dial 800-289-0485 from the U.S. or 913-981-5518 internationally. Individuals interested in listening to the live call via webcast may do so by visiting www.medivation.com. A replay of the webcast will be available on the Company's website for 3
'"/>




Page: 1 2 3

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimers Disease Conference
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... MIRAGE, Calif., March 27 In the medical,community at ... attacks kill,and destroy cells in the heart muscle. Multiple ... stimulate the heart to repair,itself after an individual suffers ... The Weil Institute of Critical Care Medicine, located in ...
... Discovery Support Program, HAMBURG, Germany and ... (Frankfurt Stock Exchange: EVT) announced today that ... Japan) signed a new drug,discovery agreement targeting ... collaboration applies Evotec,s proprietary fragment-based drug,discovery platform, ...
Cached Medicine Technology:Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 3
(Date:5/21/2013)... LOUISVILLE, Ky. Grapefruits have long been known ... may revolutionize how medical therapies like anti-cancer drugs ... of Louisville researchers have uncovered how to create ... have discovered how to use them as drug ... Qilong Wang, Ph.D., and their team today (May ...
(Date:5/21/2013)... OK (PRWEB) May 21, 2013 Representatives with ... been such a success that the company has achieved its ... plan from day one was to move Hammerhead Bicycles from ... Spokesman and President Scott Robertson. , Robertson explained that the ... and continue to exclusively focus on all things 29er and ...
(Date:5/21/2013)... May 21, 2013 TheBeautyPlace.com helps brides ... TheBeautyPlace.com features a Big Day Kit including all the ... need to shine on their Wedding Day. , TheBeautyPlace.com ... smile about on their Wedding Day. Flowers blooming and ... start of wedding season. From Memorial Day to October, ...
(Date:5/21/2013)... EMBO announced today that 52 outstanding researchers in ... Forty-three of the researchers reside in Europe and neighboring ... Associate Members from Canada, China, India, Japan and the ... life scientists. , "Our members are the basis for ... Leptin said. "We have been building our network of ...
(Date:5/21/2013)... Madison, WI (PRWEB) May 21, 2013 ... will converge at the premier “Start Me Up” Emerging ... for Executive Education in Madison, Wisconsin. This new ... Conference 2013, a gathering of national healthcare leaders being ... Education at the University of Wisconsin. , Funding for ...
Breaking Medicine News(10 mins):Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:EMBO announces 52 new members for 2013 2Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2
... A group ... Jackson Healthcare. The Hospital Charitable Service Awards have been created to find and celebrate ... ... A group of senior healthcare executives have joined forces to launch a new awards program ...
... BOSTON (May 25, 2010) Longtime environmental health ... the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous ... In a review article published online May 25 ... express the need for more complex strategies for ...
... a new influenza vaccine that brings science one step closer ... for seasonal flu shots. The new findings can be ... first online, open-access journal published by the American Society for ... narrow range of influenza virus strains," said Peter Palese, Ph.D., ...
... Suggestions include ,presumed consent, and priority for those who pledge ... transplants save thousands of lives every year, but many more ... of organs. While proposals to increase the supply have ... -- or even if they should be tried at all. ...
... ... and earn money for college, by entering the B’nai B’rith International Diverse Minds Youth ... grade-schoolers about tolerance and diversity. The winners take home $5,000 college scholarships and will ... ...
... Arnhem -- On 8 May an editorial about the Reduction ... H. Schrder and Monique J. Roobol was published in the ... of the European Association of Urology (EAU). The ... 1, 2010 in the New England Journal of Medicine ...
Cached Medicine News:Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 2Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 3Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 4Health News:Endocrine-disrupting chemicals pose cancer risk 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 3Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2Health News:European Urology: Editorial about REDUCE trial underlines value of dutasteride 2
... ago, Zyderm® and Zyplast® injectable collagen implants ... for smoothing facial lines, wrinkles and scars ... supplement the skins natural collagen, require minimal ... more than one million people worldwide have ...
... Captique is a non-animal stabilized ... newest HA filler to enter the ... correction of moderate to severe facial ... folds). Captique is injected just under ...
... Radiesse brings you into the new ... can now offer your patients immediate, long-term ... and flexibility. This injectable filler offers superior ... cosmetic and reconstructive treatments. Long-lasting, Radiesse saves ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
Medicine Products: